WELL Health Buys MyHealth Partners
It’s been a busy year for WELL Health Technologies Corp. (TSX.V: WELL). In early February, the company announced the acquisition of CRH Medical Corporation (NYSE: CRHM), which provides physicians with innovative services and products for the treatment of gastrointestinal diseases, for $292.7 million. Following that, in March the company purchased Intrahealth, a Vancouver-based healthcare software company, for a modest $12.16 million. Now, WELL Health is adding MyHealth Partners Inc. to its growing portfolio of companies. MyHealth Partners provides specialty care, telehealth services and accredited diagnostic health services provider that owns and operates 48 locations across Ontario.... Read More »
One Medical Buys Iora Health
The primary care clinic operator One Medical (NASDAQ: ONEM) has expanded its network size with the acquisition of Boston, Massachusetts-based Iora Health. Under the terms of the agreement, Iora Health shareholders will receive 56.1 million shares of One Medical stock valued at the company’s closing price of $35.59 on June 4, 2021, or approximately $2.1 billion in total deal value. Iora Health shareholders are expected to own approximately 26.75% of the combined company. Iora Health is a national network of primary care clinics offering holistic, personalized care to patients through online and in-person sessions with individual health coaches. The company provides services such as... Read More »
P3 Health Partners Goes Public
The private equity-backed P3 Health Partners is going public in a multi-billion-dollar merger with a SPAC. P3 Health Partners is merging with Foresight Acquisition Corp. (NASDAQ: FORE), and the combined company will have an estimated post-transaction enterprise value of $2.3 billion with an estimated equity value of $2.4 billion from the contribution of at least $180 million in cash proceeds from the transaction. P3 Health Partners was a portfolio company of Chicago Pacific Founders, which is exiting its investment in the company. P3 Health Partners is a patient-centered and physician-led population health management company that supports providers, physicians and practices as they... Read More »
Charles River Laboratories Buys Vigene Biosciences
The global contract research organization Charles River Laboratories International, Inc. (NYSE: CRL) is back with a new deal for Vigene Biosciences, Inc. The deal is valued at $292.5 million in cash up front, plus contingent additional payments of up to $57.5 million based on future performance. Vigene Biosciences is a gene therapy contract development and manufacturing organization (CDMO) providing viral vector-based gene delivery solutions. The acquisition of Vigene Biosciences will enhance Charles River’s gene therapy capabilities in the high-growth, value-added cell and gene therapy CDMO sector. Vigene is expected to generate annual revenue of $30 to $35... Read More »
Thermo Fisher Bets $20 Billion on Leading CRO
The laboratory and diagnostics giant Thermo Fisher Scientific Inc. (NYSE: TMO) announced a huge deal for an international contract research organization (CRO) last week. Thermo Fisher is buying PPD, Inc. (NASDAQ: PPD), a leading CRO providing broad, integrated drug development, laboratory and lifecycle management services. Its customers include pharmaceutical, biotechnology, medical device, academic and government organizations. The company has offices in 47 countries and more than 26,000 employees. Its headquarters is based in Wilmington, North Carolina. Thermo Fisher is offering $17.4 billion for PPD, or $47.50 per share for the company, a premium of approximately... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
